The Bronchopulmonary Dysplasia Drug Market is attracting pharmaceutical and biotechnology investment as companies explore new approaches for neonatal respiratory disease. The market is projected to expand from USD 2.1 billion in 2025 to USD 3.5 billion by 2035, with research partnerships playing an important role in strengthening the therapeutic pipeline. The report identifies collaborations...